CAM
CELU icon

Cresset Asset Management’s Celularity CELU Stock Holding History

Cresset Asset Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35,000
Closed -$104K – 1838
2024
Q3 		$104K Hold
35,000
– – ﹤0.01% 2040
2024
Q2 		$110K Hold
35,000
– – ﹤0.01% 1946
2024
Q1 		$183K Buy
+35,000
New +$144K ﹤0.01% 1785

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
KFS
Keynote Financial Services Vernon, Connecticut $214M AUM 60.12% 1-Year Est. Return

Cresset Asset Management's CELU Position: Q4 2024 in Review

Cresset Asset Management sold out of Celularity (CELU) in Q4 2024, closing a stake of 35,000 shares — an estimated $104K sold.

Cresset Asset Management first reported a position in CELU in Q1 2024 and held it in 3 quarters. The position peaked at $183K in Q1 2024. 32 funds tracked by Wall St. Rank hold CELU as of Q4 2024.

  • Cresset Asset Management reported no remaining Celularity position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 35,000 Celularity shares in Q4 2024, an estimated $104K.
  • Cresset Asset Management first reported a position in Celularity in Q1 2024 and held it in 3 quarters.
  • Cresset Asset Management's Celularity position peaked at $183K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held Celularity as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.